Skip to content

Clinical trials

Completed Phase 1/2 Immune System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 1/2 Status: Completed Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20104
20111
20123
20142
20163
20211
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)3
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud2
St. Petersburg State Pavlov Medical University2
AO GENERIUM1
Alladapt Immunotherapeutics, Inc.1
Ariad Pharmaceuticals1
Astex Pharmaceuticals, Inc.1
Celgene1
Inmagene LLC1
Jasper Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases20
Immunoproliferative Disorders4
Autoimmune Diseases3
Communicable Diseases3
Hematologic Diseases3
Lymphoproliferative Disorders3
Rare Diseases3
Virus Diseases3
Blood Protein Disorders2
Bronchiolitis Obliterans Syndrome2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.